BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9137379)

  • 1. [Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
    Georges B; Brown L; Mazerolles M; Decun JF; Cougot P; Archambaud M; Suc C; Andrieu P; Virenque C
    Presse Med; 1997 Apr; 26(11):502-6. PubMed ID: 9137379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
    Haag R
    Infection; 1986; 14(1):38-43. PubMed ID: 3957435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
    Apisarnthanarak A; Mundy LM
    Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
    Kitzis MD; Goldstein FW
    Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features.
    Denis O; Nonhoff C; Byl B; Knoop C; Bobin-Dubreux S; Struelens MJ
    J Antimicrob Chemother; 2002 Sep; 50(3):383-91. PubMed ID: 12205063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe infections caused by methicillin-resistant Staphylococcus aureus. 62 cases].
    May T; Janbon F; Beuscart C; Meyran M; Roue R
    Presse Med; 1993 May; 22(19):909-13. PubMed ID: 8378281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
    del Río A; Gasch O; Moreno A; Peña C; Cuquet J; Soy D; Mestres CA; Suárez C; Pare JC; Tubau F; Garcia de la Mària C; Marco F; Carratalà J; Gatell JM; Gudiol F; Miró JM;
    Clin Infect Dis; 2014 Oct; 59(8):1105-12. PubMed ID: 25048851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of methicillin-resistant Staphylococcus aureus bacteremia unresponsive to Vancomycin by adding fosfomycin: a case report.
    Linasmita P
    J Med Assoc Thai; 2012 Jul; 95(7):960-3. PubMed ID: 22919993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
    J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin].
    Silbermann MH; Gyssens IC; Wielenga JJ; Endtz HP; Löwenberg B
    Ned Tijdschr Geneeskd; 1995 Dec; 139(48):2498-501. PubMed ID: 8532088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Olay T; Vicente MV; Rodríguez A
    J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
    Aepfelbacher M
    MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance.
    Bernard L; Vaudaux P; Vuagnat A; Stern R; Rohner P; Pittet D; Schrenzel J; Hoffmeyer P;
    Infect Control Hosp Epidemiol; 2003 Sep; 24(9):650-4. PubMed ID: 14510246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
    Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB
    J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.
    Lau WY; Teoh-Chan CH; Fan ST; Lau KF
    J Hyg (Lond); 1986 Jun; 96(3):419-23. PubMed ID: 3637200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
    Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
    J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
    Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
    Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
    Kono K; Takeda S; Tatara I; Arakawa K; Tanaka H; Miyake S; Minamikawa H; Hoshino H; Sato M; Hattori F
    Jpn J Antibiot; 1994 Jun; 47(6):798-803. PubMed ID: 8072189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Fantin B; Leclercq R; Duval J; Carbon C
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2466-9. PubMed ID: 8285635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.